Jiangsu Nanfang Medical Co., Ltd. (603880.SS) SHH

Currency In CNY

AD

Valuation

Market Cap1.8B
Enterprise Value2.24B
P/E Ratio-22.7
PEG Ratio-0.51
Price/Sales Ratio4.32
Price/Book Ratio15.32
Enterprise/Revenue5.05
Enterprise/EBITDA-64.86

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.19
Operating Margin-0.15
AD

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.56

Income Statement

Revenue598.58M
Revenue/Share1.96
Gross Profit5.41M
EBITDA-24.21M
Net Income-101.71M
Diluted EPS-0.35

Balance Sheet

Total Cash57.95M
Total Cash/Share0.2
Total Debt447.74M
Total Debt/Equity2.81
Current Ratio0.45
Book Value Per Share0.59

Price History

52-Week Change39.9
52-Week High10.39
52-Week Low5.3
Moving Average 50 Days8.41
Moving Average 200 Days7.36

Statistics

Average Volume11.69M
Shares Outstanding289.04M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.17
Last Split Factor13:10
Last Split DateMay 21, 2021
AD